Company Overview and News
The energy regulator is on the hunt for an company in the sector willing to take on the 10,000 customers left stranded in the wake of another collapsed provider in the industry.
Two energy supply minnows have failed to meet a key payment deadline for the Government’s warm home discount scheme, fuelling growing fears of a financial crunch for small suppliers due to rising costs in the crowded market.
GB Energy Ltd (ASX:GBX) has been granted a trading halt by the ASX in afternoon trade, pending details in relation to the Kalia Holdings Pty Ltd acquisition.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND, JAPAN OR ANY JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
Thousands of households are being hit with 40%-plus increases to their gas and electricity bills – far above the price hikes announced by the big energy firms in recent months. A combination of sneaky changes to billing structures, regional variations and the fact that many popular fixed-price tariffs have come to an end have left furious Guardian Money readers complaining that their bills are set to rise by £300 to £400 a year, contrary to official price rise figures from the major providers.
The independent energy company behind the retail market’s cheapest deal has shut its doors to new consumers amid concern over its mounting complaints and wafer thin cash reserves.
Denver Mckay is used to being cold. Heating his one-bedroom flat in Hamilton, just outside Glasgow, is a luxury he can’t always afford. “I pay £20 a week now and this is a struggle,” he said. “Sometimes I have to go without the heating on at all. Sometimes it’s just one room.”
GB Energy (ASX:GBX) has been granted a trading halt by the ASX, with its shares placed in pre-open.
New supplier hopes to sign up 40,000 single variable tariff customers in first year, two months after collapse of GB Energy UK
Customers will be charged 4.9p per unit of electricity from 11pm to 6am but up to five times as much during peak demand times
The financial year can be gauged by the words it adds to the dictionary – and those that pass into obscurity. So 2016 gave us Hard Brexit, a sugar tax and Pokémon Go. Lost to the lexicon are GB Energy, Friends Reunited and Samsung’s quickly recalled Galaxy Note 7. But some words previously designated obsolete have returned: welcome back British Steel, revived by Greybull Capital, while Morrisons resurrects Safeway.
The 22-year-old believed to be Britain’s youngest energy boss has insisted that navigating gas and power markets is “simple economics”, amid rising fears over the financial health of start-up suppliers.
Safety issues force many reactors offline prompting warnings of power cuts across France, higher energy prices and a rise in emissions
The UK's biggest supplier follows rival SSE in pledging no hikes until next spring as the sector remains under political pressure.
Energy giant British Gas has announced a price freeze for more than six million customers on standard tariffs over the winter.
2018-05-25 - Asif
Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...
2018-05-25 - Asif
Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...